# Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis

> **NCT02346877** · PHASE4 · TERMINATED · sponsor: **Amgen** · enrollment: 19 (actual)

## Conditions studied

- Persistence to Enbrel

## Interventions

- **BEHAVIORAL:** Personalized Patient Counselling

## Key facts

- **NCT ID:** NCT02346877
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Business Decision
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02346877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02346877, "Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02346877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*